Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Sequencing Ebola’s Secrets

June 18, 2015 By Harvard University

Last June, in the early days of the Ebola outbreak in Western Africa, a team of researchers sequenced the genome of the deadly virus at unprecedented scale and speed. Their findings revealed a number of critical facts as the outbreak was unfolding, including that the virus was being transmitted only by person-to-person contact and that it was picking up new mutations through its many transmissions.

While public health officials now believe the worst of the epidemic is behind us, it is not yet over, and questions raised by the previous work still await answers.

To provide them, a global team from Harvard University, the Broad Institute, the U.S. Centers for Disease Control and Prevention (CDC), and the National Institute of Allergy and Infectious Diseases (NIAID, part of the National Institutes of Health), along with many other institutions*, sequenced more than 200 additional genomes from Ebola virus samples, to capture the fullest picture yet of how the virus is transmitted and how it has changed over the long-term outbreak.

In an effort to enhance the global response, this team made their data publicly available as it was produced throughout last year. “One of the most rewarding aspects of working in this outbreak response is the connections we have made with so many extraordinary individuals through open data sharing”, said senior author Pardis Sabeti. The global team that assembled as a result has now described their analysis in a June 18 paper published in Cell.

“Our early work tracked the virus’s movements over just three weeks as the outbreak emerged in Sierra Leone,” said Sabeti. “Now with a view of the virus over seven months, we can understand how it has been moving and changing over the long term.”

“One insight we gained from this high resolution sequence data is that later in the outbreak, there was very little cross-border exchange of the virus,” said lead author Danny Park. “That’s important, because the three main affected countries–Sierra Leone, Liberia, and Guinea–are often described as having ‘porous borders’ which allowed people to travel back and forth.”

While cross-border contact may have helped fuel the early days of the outbreak, Park said it’s now clear that, once underway, the virus didn’t migrate in the ways many had predicted. “This is very reassuring to know that measures to contain the outbreak at borders can work,” he said, “and allows attention to be focused on within-country movement.”

The new sequencing also provides insight into viral evolution over the sustained outbreak. Early in the outbreak, as the virus spread rapidly, it accumulated many mutations, a disproportionate share of which could affect protein function. Last August, the researchers noted that most of these were likely to be damaging to the virus, but that the outbreak hadn’t gone on long enough for natural selection to weed them out yet.

Over the longer term, the team observed that many of these mutations did not persist very long, and that the rate of change in the viral genome has become more in line what is expected over the longer term. “Ebola has never been exposed to humans for so long, and through so many transmissions, it has begun to weed out mutations that do not benefit it,” Park said.

The team also identified other changes of the virus that are expected over the longer-term. For example, in some patients, they saw evidence of human enzymes editing the viral genome. This has never before been seen for Ebola, and is only seen previously with viruses that have long-standing interactions with humans.

“The many mutations we saw early in the outbreak and the evolution we saw over the long-term have been observed for other viruses before, and the genomic data only helps illuminate known evolutionary phenomena.” Sabeti says. “The data just remind us what we have always known, that we must get this viral lineage to zero.”

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe